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Abstract
Background: Japanese encephalitis (JE) is a serious zoonosis caused by the Japanese encephalitis virus (JEV) which
is a mosquito-borne pathogen of the family Flavivirus. However, the application of several developed laboratory
methods for the detection of JEV antigens or antibodies are limited by their requirements of laboratory operations,
skilled technicians and special facilities.
Results: To develop a method for detecting JEV antigen in swine, human, mosquito and other clinical specimens
specifically, conveniently and effectively, an antigen capture enzyme-linked immunosorbent assay (ELISA) was
established in this study. Sensitivity, specificity, repeatability and stability of the developed method were evaluated,
and 60 clinical samples were tested in this study. The results demonstrated that the antigen capture ELISA was
capable in detecting JEV antigen with high sensitivity and specificity compared with conventional methods. 14
samples showed the positive result with coincidence rate of 70%, and 46 displayed negative result with
coincidence rate of 100% as compared to that of reverse transcription-polymerase chain reaction (RT-PCR).
Conclusions: The developed ELISA assay provides a convenient and specific method for the large-scale
determination of JEV antigen in infected swine, human and mosquito samples with high sensitivity and specificity.
Keywords: Japanese encephalitis, Japanese encephalitis virus, Monoclonal antibody, Polyclonal antibody, Antigen
capture ELISA
Background
Japanese encephalitis (JE) is a serious mosquito-borne
zoonosis caused by the Japanese encephalitis virus (JEV)
which threatens public health in southern and eastern
Asia. In general, JEV is maintained in a transmission
cycle between amplifier swine and vector mosquitoes [1].
As a dead-end, humans are infected by bites of infectious
mosquitoes and subsequently develop neurological dis-
eases with an estimated 10,000 JE-related deaths annually
[2-5]. As an important pathogen in swine, it also induces
terrible consequences in sows reproduction and death in
piglets [6,7].
JEV, a member of the Flaviviridae family, contains a
single positive 11-kb RNA genome with three structural
proteins and seven nonstructural proteins [8,9], in which,
E protein is the major immunogenic protein of JEV. It
has the ability to induce neutralizing antibodies and is
recognized as a protein candidate for the development of
vaccines and diagnosis methods [10].
Several laboratory methods have been developed for
the detection of JEV infection, such as virus isolation,
RT-PCR. However, even with the most advanced labora-
tory facilities, JEV cannot be isolated from clinical speci-
mens easily, probably because of low circulating viral
numbers, soon clearance of transient viremia after onset
of illness and the rapid production of neutralizing antibo-
dies [11,12]; in addition, RT-PCR requires experienced
technicians and specialized laboratory equipment, and
serological test such as Hemagglutination inhibition test
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or to monitor the immunization situation. More impor-
tantly, these methods are not appropriate for investigat-
ing large numbers of samples and detecting of the level
of JEV antigens in variety kinds of clinical samples.
Currently, enzyme-linked immunosorbent assay (ELISA)
has been used widely for the detection of JEV infection.
For example, antibody capture ELISA had been applied to
detect IgM of JE in serum [13], Eiji Konishi established
ELISA for quantifying antibodies against JEV nonstruc-
tural 1 protein to detect subclinical infections in vacci-
nated horses [1], and Sithiprasasna R developed an
indirect ELISA for detecting flavivirus antigen in mosqui-
toes [14], however, the application of highly specified
ELISA method for the detection of JEV antigen in swine,
human, mosquito and other clinical samples uniquely and
effectively hasn’t been reported yet.
In this study, we aimed to develop a highly specific, sen-
sitive, and economical antigen capture ELISA assay for
detection of JEV antigen in swine, human, mosquito and
other clinical samples, in an attempt to provide an effec-
tive tool for diagnosis of JEV infection.
Results
Production and characterization of MAb and PcAb
against JEV
A highly specific monoclonal antibody (MAb) against JEV
E protein, named 4D1, had been confirmed to take on
strong immunoreactivity with E protein by Western blot
and immunofluorescence assay (IFA) [10]. And we found
that the reaction titer of the polyclonal antibody (PcAb)
produced could also reach up to 1:20000 through indirect
ELISA test. As shown in Figure 1, a strong fluorescent sig-
nal could be detected in the JEV-infected BHK-21 cells in
t h eI F A .B yc h e c k e r b o a r dt i t r a t i o n ,o p t i m a lc o n c e n t r a t i o n s
of the primary antibody (E MAb) and the detection anti-
body (PcAb) were defined as 5 ug/ml and 0.2 mg/ml,
respectively.
Sensitivity of the ELISA assay
1×1 0
6 PFU/ml JEV was serially diluted and tested by
ELISA test. As shown in Figure 2, a standard curve for
the 10-fold diluted 1 × 10
6 PFU/ml JEV test was con-
structed and the homogenate from blank mouse brain
was used as the negative control to establish the baseline.
The result showed that the minimum virus amount for
detection was 1.0 × 10
4PFU.
Specificity of the ELISA
To evaluate the specificity of the ELISA assay, other
viruses relating with popular viral diseases were subjected
to this assay. As comparison, all the virus samples were
also detected by RT-PCR. As shown in Table 1, positive
results were observed in standard positive control and
negative results were shown in PRV, PCV, PRRSV, PPV,
CSFV and SIV. In addition, a weak positive signal was
detected in one of the five inactivated WNV samples. The
cross-reactivity between JEV and WNV was difficult to
avoid because of the high homology of them. However,
the specificity of the ELISA test would not be interfered by
this weak signal of cross-reactivity.
Repeatability, stability and shelf time of the ELISA assay
The repeatability of the ELISA assay was evaluated with
five samples. The coefficients of variation of three samples
tested in this assay were 6.7%, 6.1% and 7.6% respectively
(Table 2). Additionally, there was no distinct difference
discovered in multiple times detection of each sample
with two coated microtiter plates by significance analysis
(P > 0.05), which confirmed the high repeatability of this
JEV MOCK
Figure 1 PcAb reactionogenicity and specificity were identified by IFA. BHK-21 cell incubated with JEV for 1 h at 37°C. At 72 h post-
infection, cells were fixed with absolute methanol and treated for IFA with the prepared PcAb against JEV. Normal BHK-21 without infected JEV
as a control (MOCK).
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the plates coated with MAb 4D1 were stored at 37°C. The
OD630 values of the standard positive control and the
standard negative control were shown with no significant
decrease for at least 5 days (Table 3). In addition, the
plates coated with the E MAb 4D1 could be stored at 4°C
or -20°C for up to 6 months without any deterioration of
the coating antibody (Table 4). These data suggested that
the ELISA assay has good repeatability, and the stability
and shelf time could reach to the standards of ordinary
ELISA tests.
Clinical sample detection
By RT-PCR analysis, 20 out of 60 clinical samples were
positive and 40 were negative. Whereas the ELISA test
showed 14 positive and 46 negative results with the
positive coincidence rate of 70%, and the negative coin-
cidence rate of 100% (Table 5).
Discussion
JE is a severe zoonosis which induces fever, aseptic
meningitis, acute flaccid paralysis or classic meningomy-
leoencephalitis, and up to 50% of persons who survive it
may have prolonged neurological or psychiatric sequelae
[15-18]. Currently, there is an urgent need of a rapid
diagnosis method for detection of JEV infection in both
humans and animals. Since the inoculation of JEV vac-
cines contributes to the result of antibody-positive, the
accurate diagnosis still depends on the antigen detec-
tion. However, the application of conventional methods,
such as RT-PCR and viral isolation, are limited by their
requirements of laboratory operations, skilled techni-
cians and special equipments. Therefore, a more simple
and rapid method for the detection of JEV antigen is
needed to be developed.
Herein, we reported a convenient antigen capture
ELISA for the diagnosis of JEV infection by using the
MAb 4D1 against E protein of JEV and the PcAb of JEV
derived from the rabbits. Because the JEV-specific pri-
mary antibody and anti-antibody are used, the proposed
ELISA in this report is shown to hold the characteristic
of detecting JEV antigen specifically, which effectively
reduces and clears the interference from other flavivirus
for JEV diagnosis. In addition, as the major immunogenic
gene, E gene is highly conservative in different JEV geno-
types. It has been shown that the E MAb produced by
Yaoming Li according to the nucleotide sequence of E
Figure 2 Sensitivity of antigen capture ELISA assay.1×1 0
6 PFU of JEV was 10-fold diluted serially (1:10 to 1:100,000) for the test; the
homogenate from blank mouse brain was used as the negative control.
Table 1 Specificity of ELISA assay for different virus





JEV(P3) 15 13/2 15/0
PRV 7 0/7 0/7
PCV 8 0/8 0/8
PRRSV 8 0/8 0/8
PPV 6 0/6 0/6
WNV(inactivated) 5 1/4 0/5
CSFV 9 0/9 0/9
SIV 5 0/5 0/5
Healthy control 15 0/15 0/15
a Antigen capture ELISA assay
b Reverse transcription polymerase chain reaction
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prevalence-predominant JEV genotype I [10], which sug-
gested that our ELISA assay could be applied to clinical
detection of different JEV genotypes.
Specific binding between antibody and antigen is the
most important factor for the successful development of
ELISA assay. In previous studies, specificity of the test has
been modified by use of monoclonal antibodies of single
strains or multiple strains. However, polyclonal antibodies
are typically chosen to enhance sensitivity [19,20]. There-
fore, in this study, the polyclonal antibody rather than the
monoclonal antibody against JEV is applied for conjugat-
ing with the antigen as detection antibody, since our
results have showed that polyclonal antibodies could
recognize more JEV strains, which improves the sensitivity
of test.
Taken together, the ELISA assay developed in this
study has following potential advantages. First, unlike
RT-PCR and other viral isolation methods, our ELISA
assay does not require expensive reagents and special
facilities, and it can be routinely performed in any
ordinary laboratory because of its simplicity and rapid-
ity. Second, the ELISA assay has been confirmed with
relatively high sensitivity. The minimum detection level
of our ELISA assay (1.0 × 10
4 PFU) is lower than that of
RT-PCR (3.2 × 10
2 PFU), but higher compared with that
of immunochromatographic strip (ICS) (2.5 × 10
5 PFU)
[10]. Since the ineluctability of false positive reaction by
RT-PCR and the low sensitivity of ICS always prevent
the applying of these methods for accurate diagnosis of
JEV, our ELISA assay may be developed as an alterna-
tive method for fast diagnosis of JEV infection. Addi-
tionally, the higher sensitivity with our capture ELISA
for detecting JEV antigen than with traditional ELISA
has been confirmed in our assay, it could be due to
introducing of a horseradish peroxidase (HRP)-labeled
goat anti-rabbit antibody for specifically identifying
detection antibody, which has amplified the reaction sig-
nals in whole system and modified the sensitivity. Most
importantly, this ELISA assay provides a convenient way
f o rd e t e c t i n gJ E Vi nal a r g en u m b e ro fc l i n i c a ls p e c i -
mens including swine, human and mosquito, which has
not been reported before. Therefore, this method will
have a broad application prospect in large-scale clinical
diagnosis of JEV.
However, there are still some problems cannot be
ignored. Samples collected at an appropriate time is
required in this ELISA test when the virus in the
detected samples has not been degraded. Because the
timing of sample collection impacts on the ability to
confirm the diagnosis of JEV [21] and that is necessary
for successful detection by any technique. Moreover
slight infection with JEV may not be capable of being
detected by our ELISA test, it is due to the fact that
some samples lightly infected with JEV have negative
results with this ELISA but positive results by RT-PCR
which has ability to detect lower virus load. Thus the
ELISA test in this study is more suitable for diagnosis of
severe JEV infection during an exhaustive outbreak in
farm. It is necessary that these suspected samples with-
out classical symptom of JEV infection should be further
confirmed by other techniques, such as histological,
immunological, or molecular assays.
Conclusions
In summary, we successfully developed an antigen cap-
ture ELISA assay which could detect JEV antigen in
swine, human, mosquito and other samples specifically
and effectively, indicating that this ELISA assay could be
employed as a fairly simple and efficient tool for clinical
detecting and controlling JEV infection.
Table 2 Repeatability of ELISA assay for 5 different samples
Detection No. ELISA OD630
Specimen No. Plate 1 Plate 2 AVG SD CV p-Value
123456
1 0.46 0.499 0.535 0.475 0.442 0.49 0.484 0.0325 6.70% 0.1626
2 0.231 0.204 0.207 0.211 0.213 0.192 0.21 0.0128 6.10% 0.2346
3 0.126 0.126 0.125 0.148 0.12 0.127 0.129 0.0098 7.60% 0.2577
AVG Average of 6 detection OD630 values for each sample
SD Standard deviation of 6 detection OD630 values for each sample
CV Coefficient of variation of 6 detection OD630 values for each sample
p-Value The significance difference analysis between plate 1 and plate 2 as inter-repeat assay







Day 1 0.894 ± 0.008 0.150 ± 0.012
Day 2 0.888 ± 0.004 0.145 ± 0.007
Day 3 0.852 ± 0.027 0.144 ± 0.034
Day 4 0.796 ± 0.045 0.167 ± 0.051
Day 5 0.738 ± 0.007 0.129 ± 0.002
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Virus preparation
JEV wide type strain P3 was propagated in brains of
suckling mice and the negative control was prepared
with the blank mouse brain. Pseudorabies virus (PRV,
Ea strain), Porcine circovirus (PCV-2, Yu-A strain), Por-
cine reproductive and respiratory syndrome virus
(PRRSV, YA strain), Porcine parvovirus (PPV), West
Nile virus (WNV, inactivated), Classical swine fever
virus (CSFV, CWH strain) and Swine influenza virus
(SIV) were stored in the laboratory.
Antibodies preparation
The MAb against JEV E protein was produced in our
laboratory as reported by Li et al. [10]. The harvested
MAb was purified by NAbTM Protein A/G Spin Assay
(Thermo Scientific, Rockford, USA) according to the
manufacturer’s instructions. To produce the PcAb
against JEV, rabbits were immunized subcutaneously
with emulsified JEV vaccine by Freund’si n c o m p l e t e
adjuvant (SIGMA, USA). After the fourth immunization,
blood was collected and serum was separated. The PcAb
w a sh a r v e s t e da n dp u r i f i e df r o mt h es e r u m .I t sa c t i v i t y
was characterized by IFA.
The assembling of the ELISA
The MAb was diluted to 5 ug/ml in coating buffer (0.05 M
sodium carbonate, pH 9.5-9.7) and added into the 96 wells
of polystyrene microtiter plates (KeQian Animal Biological
Products Co., Ltd, Wuhan, China). After overnight incuba-
tion at 4°C, the plates were washed five times with rinse
solution (0.05% Tween-20 in PBS). Nonspecific binding
was blocked with blocking solution (1% bovine serum
albumin in PBS) at 37°C for 1 h. Subsequently, 100 ul/well
of serial diluted samples, were added in. After 30 min of
incubation at 37°C, 100 ul of the PcAb against JEV, diluted
in 1:10000 by blocking solution, was added as a detection
antibody. After another 30 min incubation at 37°C, horse-
radish peroxidase (HRP)-labeled goat anti-rabbit IgG
(BOSTER, Guanshan Road, Wuhan, China) was added
and incubated for 30 min. Between each step, plates were
washed five times in rinse solution for 2 min. After the
conjugation step, tetramethylbenzidine (TMB) was added,
and the result was measured by a spectrophotometer at a
wavelength of 630 nm.
The cut-off standard and detection criteria of ELISA assay
In this study, a background subtraction method was
used as the border value between positive and negative,
which referred to the manufacturer’si n s t r u c t i o n so f
PRRSV Ab ELISA Manual (Ver.1.0) PRRSV-VR/PRRSV-
LA (VDPro, JENO Biotech Inc., Korea).
Test validation: OD mean of positive control (PC):0.4
or above OD mean of negative control (NC):0.2 or less
Calculation of CPC (Corrected Positive Control): CPC
= OD mean of PC - OD mean of NC
Calculation of SP (Sample to Positive ratio): SP = (OD
mean of sample - OD mean of NC)/CPC
The Cut-off standard of our method was set as
follows:
A sample was defined as positive if the SP value was
more than 0.4 and as negative if the SP value was less
than 0.2. When SP value was between 0.2 and 0.4, the
sample was defined to be suspect. If the detection value
is suspect, the samples are needed to be collected from
the herd after 1 month and tested again for confirmation.
Sensitivity and specificity tests of the ELISA
JEV stock (1 × 10
6 PFU/ml) was diluted 10-fold succes-
sively. Each dilution was applied to the ELISA test. The










One Month 0.962 ± 0.037 0.168 ± 0.009 0.898 ± 0.058 0.155 ± 0.061
Two Months 0.934 ± 0.041 0.155 ± 0.014 0.845 ± 0.025 0.147 ± 0.039
Three Months 0.878 ± 0.014 0.145 ± 0.023 0.797 ± 0.006 0.115 ± 0.011
Four Months 0.863 ± 0.023 0.127 ± 0.008 0.752 ± 0.009 0.104 ± 0.008
Five Months 0.856 ± 0.005 0.139 ± 0.012 0.793 ± 0.052 0.113 ± 0.043
Six Months 0.832 ± 0.034 0.143 ± 0.051 0.721 ± 0.048 0.133 ± 0.029
Table 5 Results of JEV detection by ELISA assay and RT-






Positive 14 0 14
Negative 6 40 46
Total 20 40 60
Compared to RT-PCR, the positive coincidence rate of ELISA:
14/(14 + 6) × 100% = 70%; the negative coincidence rate of ELISA: 40/(40 + 0)
× 100% = 100%; the total coincidence rate: (14 + 40)/60 = 90%;
a Antigen capture ELISA assay
b Reverse transcription polymerase chain reaction
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tion according to the cut-off standard prescribed. The
specificity of the ELISA was evaluated by detecting sev-
eral different viruses including PRV, PCV, PRRSV, PPV,
inactivated WNV, CSFV and SIV. 1.0 × 10
6 PFU/ml JEV
strain was used as positive control, while the homoge-
nate from healthy mouse brain was used as negative
control.
Repeatability, stability and shelf time evaluation of the
ELISA assay
In regard to the repeatability evaluation, the ELISA
assay was utilized to detect 3 samples with two groups
of coated microtiter plates. Each sample was tested
three times separately in one plate for intra-repeat assay
and results in two plates were regarded as inter-repeat.
The differences were evaluated through comparing var-
iation coefficient and analyzing statistical significance.
To analyze the stability of the ELISA assay, the coated
polystyrene ELISA plates were placed in 37°C incubator.
Standard positive control and negative control were
detected by one ELISA plate each day. To determine the
s h e l fl i f eo ft h eE L I S Aa s s a y, the coated ELISA plates
were put into 4°C and -20°C respectively for several
months. One piece of the coated plate was used to
detect the standard positive control and negative control
each month.
Detection of clinical samples in field
60 clinical samples (including 20 mosquito homogenate,
24 swine brain tissues and 16 cerebrospinal fluid of the
human patients) were detected by ELISA assay. Among
which, 16 cerebrospinal fluid specimens from the
human patients at Taihe Hospital (Shiyan, China) were
collected on admission; 24 swine brain tissues were col-
lected from clinical detection; 20 mosquito species were
caught by the mosquito catcher. The clinical samples
from the mosquito, swine, and cerebrospinal fluid were
all stored at -80°C before assay. Five grams of brain tis-
sue of swine, mosquitoes in 5 ml of medium were
homogenized in a sterile grinder and centrifuged at
10,000 × g for 10 min respectively. The supernatant was
filtered with 0.22 um filter membrane and the percolates
collected as tissue samples. RT-PCR was applied as the
comparative methods.
Statistical analysis
Statistical analysis was subjected to a Student’s t test.
P > 0.05 was considered to be no significance of
difference.
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